“…ORF1ab_L3606F, which has been described as a homoplastic mutation [ 75 ], was observed in China for the first time [ 59 ] and has also been reported in studies concerning Italy [ 59 ], Brazil [ 59 ], Iran [ 108 ], Africa [ 109 ] and in other studies that do not specify geographic regions [ 62 , 67 , 68 , 69 , 120 ]. Moreover, ORF1ab_Y4847Y, which was not present in China at the early stages of the worldwide viral spread [ 110 ], was detected in large-scale studies [ 59 , 65 , 76 , 77 ] and placed in Malaysia in the third wave of the pandemic [ 110 ], in Thailand in the first wave [ 111 ], in Korea [ 112 ], in Oceania [ 77 ], in Europe [ 76 , 77 ], in Spain, in North America and in Australia [ 76 ]. ORF3a_G251V is speculated to have spread at least in January 2020 or earlier in Sweden, Italy, Brazil, Australia and the USA [ 70 ], and reached a peak in the months after, followed by its disappearance in April 2021 [ 113 ].…”